AXITILIENT

Serial Number 77873541
606

Registration Progress

Application Filed
Nov 16, 2009
Under Examination
Jun 1, 2010
Approved for Publication
Mar 17, 2010
Published for Opposition
Apr 6, 2010
Registered

Trademark Image

AXITILIENT

Basic Information

Serial Number
77873541
Filing Date
November 16, 2009
Published for Opposition
April 6, 2010
Abandonment Date
July 1, 2013
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 1, 2013
Classes
005

Rights Holder

Agouron Pharmaceuticals, Inc.

03
Address
10777 Science Center Drive
San Diego, CA 92121

Ownership History

Agouron Pharmaceuticals, Inc.

Original Applicant
03
San Diego, CA

Agouron Pharmaceuticals, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Michele Farber

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

34 events
Date Code Type Description Documents
Jul 1, 2013 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 1, 2013 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Nov 20, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Nov 19, 2012 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 15, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 15, 2012 EXT5 S SOU EXTENSION 5 FILED Loading...
May 22, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
May 18, 2012 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 16, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 16, 2012 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 1, 2011 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Nov 30, 2011 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 28, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 28, 2011 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 23, 2011 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 23, 2011 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 28, 2011 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
May 27, 2011 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 26, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 24, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 24, 2011 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 2, 2010 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Nov 30, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 30, 2010 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 30, 2010 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 1, 2010 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 6, 2010 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 17, 2010 NPUB O NOTICE OF PUBLICATION Loading...
Mar 1, 2010 ALIE A ASSIGNED TO LIE Loading...
Mar 1, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Feb 3, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 3, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 20, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 19, 2009 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005